<DOC>
	<DOCNO>NCT03021486</DOCNO>
	<brief_summary>The goal clinical research study learn chlorpromazine , high-dose haloperidol , combination 2 drug help control symptoms delirium ( loss contact reality ) patient advanced cancer respond low-dose haloperidol . High-dose haloperidol dos usually 2-4 time size low-dose haloperidol . In addition , researcher want learn treat patient drug help lessen distress caregiver may . The safety drug also study .</brief_summary>
	<brief_title>Haloperidol and/or Chlorpromazine Refractory Agitated Delirium</brief_title>
	<detailed_description>Study Groups : If find eligible agree take part , randomly assign ( roll dice ) 1 3 study group . This do one know one study group well , , bad group . You equal chance group . - If Group 1 , receive haloperidol . - If Group 2 , receive chlorpromazine . - If Group 3 , receive haloperidol chlorpromazine . Neither study staff know study drug receiving . However , need safety , study staff able find receiving . Study Drug Administration You receive study drug ( ) vein 3-15 minute every 4 hour discharge palliative care unit withdraw study . You may receive additional dos every 1 hour , need . The dose level length administration may raise lowered meet need . Length Treatment You may continue receive study drug ( ) long palliative care unit . You may stop receive study drug ( ) time and/or caregiver decide best interest . Baseline Procedures Before first dose study drug ( ) : - Your demographic information ( age , sex , date birth , race , marital status , education ) , medical information , cancer history record . - You complete test measure level delirium . To complete test , study doctor ask complete several thinking task , recall set number word , remember different object , state day . This test take less 10 minute complete . - You complete 1 questionnaire symptom may . This take 5 minute complete . Study Procedures : Every 8 hour first 24 hour palliative care unit , repeat symptom questionnaire . After first 24 hour , complete questionnaire 1 time day discharge . If recover delirium , ask complete questionnaire experience delirium . This take 5 minute complete . Your active participation study point . This investigational study . Both chlorpromazine haloperidol FDA approve commercially available treatment bipolar disorder psychotic disorder . Their use help control delirium investigational . The study doctor explain study drug design work . Up 54 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Chlorpromazine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>1 . [ Patients ] Diagnosis advance cancer ( define locally advanced , metastatic recurrent , incurable disease ) 2 . [ Patients ] Admitted acute palliative care unit 3 . [ Patients ] Delirium per DSMV criterion 4 . [ Patients ] Hyperactive mixed delirium RASS &gt; /=2 past 24 h 5 . [ Patients ] On scheduled haloperidol delirium ( &lt; /=8 mg past 24 h ) 6 . [ Patients ] Age 18 year old 7 . [ Family Caregivers ] Patient 's spouse , adult child , sibling , parent , relative , significant ( defined patient partner ) 8 . [ Family Caregivers ] Age 18 year old 9 . [ Family Caregivers ] At patient 's bedside least 4 h/day 1 . [ Patients ] History myasthenia gravis acute narrow angle glaucoma 2 . [ Patients ] History neuroleptic malignant syndrome active seizure disorder ( seizure episode within past week ) 3 . [ Patients ] History Parkinson 's disease Alzheimer 's dementia 4 . [ Patients ] History prolong QTc interval ( &gt; 500 m ) 5 . [ Patients ] History hypersensitivity haloperidol chlorpromazine 6 . [ Patients ] On scheduled chlorpromazine within past 48 h</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Malignant neoplasms independent ( primary ) multiple site</keyword>
	<keyword>Haloperidol</keyword>
	<keyword>Chlorpromazine</keyword>
	<keyword>Chlorpromazine hydrochloride</keyword>
	<keyword>Thorazine</keyword>
	<keyword>Symptom questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>Delirium</keyword>
	<keyword>Acute palliative care unit</keyword>
	<keyword>APCU</keyword>
</DOC>